Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan Griffiths

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Pulmonary Circulation|May 4, 2022
Hepatoma-derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survivalJun Yang, Anjira S Ambade, Melanie Nies, et al.
Pulmonary Circulation|September 7, 2023
Low-affinity insulin-like growth factor binding protein 7 and its association with pulmonary arterial hypertension severity and survivalGuillermo Torres, Andrew C Lancaster, Jun Yang, et al.
Pulmonary Circulation|July 17, 2025
Enhancing Drug Development for Paediatric Pulmonary Hypertension-An Integrative PerspectiveSteven H Abman, Sylvia M Nikkho, Rolf M F Berger, et al.
Chest|February 20, 2021
ST2 Is a Biomarker of Pediatric Pulmonary Arterial Hypertension Severity and Clinical WorseningMegan Griffiths, Jun Yang, Catherine E Simpson, et al.
Pediatric Research|September 14, 2020
Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survivalMegan Griffiths, Jun Yang, Melanie Nies, et al.
BMC Medicine|October 6, 2020
Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survivalJun Yang, Megan Griffiths, Melanie K Nies, et al.
The Journal of Pediatrics|October 23, 2021
Biomarkers of Pulmonary Hypertension Are Altered in Children with Down Syndrome and Pulmonary HypertensionMegan Griffiths, Jun Yang, Dhananjay Vaidya, et al.
The Journal of Pediatrics|July 27, 2020
Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial HypertensionJenny Y Chen, Megan Griffiths, Jun Yang, et al.
ERJ Open Research|June 30, 2022
<i>COL18A1</i> genotypic associations with endostatin levels and clinical features in pulmonary arterial hypertension: a quantitative trait association studyCatherine E Simpson, Megan Griffiths, Jun Yang, et al.
ERJ Open Research|October 15, 2021
The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertensionCatherine E Simpson, Megan Griffiths, Jun Yang, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Pulmonary Circulation|May 4, 2022
Hepatoma-derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survivalJun Yang, Anjira S Ambade, Melanie Nies, et al.
Pulmonary Circulation|September 7, 2023
Low-affinity insulin-like growth factor binding protein 7 and its association with pulmonary arterial hypertension severity and survivalGuillermo Torres, Andrew C Lancaster, Jun Yang, et al.
Pulmonary Circulation|July 17, 2025
Enhancing Drug Development for Paediatric Pulmonary Hypertension-An Integrative PerspectiveSteven H Abman, Sylvia M Nikkho, Rolf M F Berger, et al.
Chest|February 20, 2021
ST2 Is a Biomarker of Pediatric Pulmonary Arterial Hypertension Severity and Clinical WorseningMegan Griffiths, Jun Yang, Catherine E Simpson, et al.
Pediatric Research|September 14, 2020
Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survivalMegan Griffiths, Jun Yang, Melanie Nies, et al.
BMC Medicine|October 6, 2020
Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survivalJun Yang, Megan Griffiths, Melanie K Nies, et al.
The Journal of Pediatrics|October 23, 2021
Biomarkers of Pulmonary Hypertension Are Altered in Children with Down Syndrome and Pulmonary HypertensionMegan Griffiths, Jun Yang, Dhananjay Vaidya, et al.
The Journal of Pediatrics|July 27, 2020
Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial HypertensionJenny Y Chen, Megan Griffiths, Jun Yang, et al.
ERJ Open Research|June 30, 2022
<i>COL18A1</i> genotypic associations with endostatin levels and clinical features in pulmonary arterial hypertension: a quantitative trait association studyCatherine E Simpson, Megan Griffiths, Jun Yang, et al.
ERJ Open Research|October 15, 2021
The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertensionCatherine E Simpson, Megan Griffiths, Jun Yang, et al.
Pageof 6